JACC Basic to Translational Science · 2018 · 488 citations · 42 references
Veterinary MedicineCardiologyPharmacologyCardiovascular PharmacotherapyInflammationLipid BiochemistryAnti-inflammatory PharmacologyCardiovascular DiseaseEndothelial DysfunctionGlucagon-like Peptide-1 Receptor AgonistsInflammatory SignalingLipoprotein MetabolismAnti-inflammatory TherapeuticsAtherosclerosis Molecular MechanismsAtherosclerosis RiskAtherosclerotic ProgressionGlucagon-like Peptide 1 Receptor AgonismInflammation In Cardiovascular DiseaseLeukocyte AggregationPlaque Inflammation
) mice. This attenuation was partly independent of weight and cholesterol lowering. In aortic tissue, exposure to a Western diet alters expression of genes in pathways relevant to the pathogenesis of atherosclerosis, including leukocyte recruitment, leukocyte rolling, adhesion/extravasation, cholesterol metabolism, lipid-mediated signaling, extracellular matrix protein turnover, and plaque hemorrhage. Treatment with semaglutide significantly reversed these changes. These data suggest GLP-1RAs affect atherosclerosis through an anti-inflammatory mechanism.
42
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text
Medicine, Cardiology, Pharmacology +17